Related Experiment Video
Updated: Feb 20, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells
1Yorkshire Cancer Research P53 Laboratory, Department of Biology, University of York, York YO10 5DD, UK.
Abstract:
To dissect apoptotic genes governing the survival of colorectal carcinoma cells, we employed RNAi to silence Bcl-2 and Bcl-x(L) in isogenic clones of p53+/+ and p53-/- cells, and of Bax+/- and Bax-/- cells. We identify a novel proapoptotic function of p53 that does not require activation by genotoxic agents and that appears to be constitutively suppressed by Bcl-2. Silencing of Bcl-2 induced massive p53-dependent apoptosis. The "Bcl-2/p53 axis" requires Bax and caspase 2 as essential apoptotic mediators. This newly discovered Bcl-2/p53 functional interface represents a key regulator of apoptosis which can be activated by targeting Bcl-2 in colorectal carcinoma cells.
Insights
We discovered a new way to trigger cancer cell death in colorectal carcinoma. Targeting Bcl-2 activates a p53-dependent pathway, leading to apoptosis and potentially new cancer treatments.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Mechanisms
Background:
- Colorectal carcinoma cell survival is regulated by apoptotic genes.
- The interplay between Bcl-2, p53, and Bax is crucial in apoptosis.
- Understanding these interactions can reveal therapeutic targets.
Purpose of the Study:
- To investigate the role of Bcl-2 and Bcl-x(L) in colorectal cancer cell apoptosis.
- To identify novel proapoptotic functions of p53.
- To elucidate the molecular axis involving Bcl-2 and p53 in colorectal carcinoma.
Main Methods:
- RNA interference (RNAi) was used to silence Bcl-2 and Bcl-x(L).
- Experiments were conducted on isogenic cell clones with varying p53 and Bax statuses.
- Apoptosis induction and mediation pathways were analyzed.
Main Results:
- A novel, constitutive proapoptotic function of p53 was identified, independent of genotoxic activation.
- Bcl-2 was found to constitutively suppress this p53 proapoptotic activity.
- Silencing Bcl-2 triggered significant p53-dependent apoptosis in colorectal cancer cells.
- The identified 'Bcl-2/p53 axis' necessitates Bax and caspase 2 for mediating apoptosis.
Conclusions:
- A previously unknown functional interface between Bcl-2 and p53 regulates apoptosis in colorectal carcinoma.
- Targeting Bcl-2 can activate this axis, inducing p53-dependent apoptosis.
- This discovery offers a potential therapeutic strategy for colorectal cancer by modulating the Bcl-2/p53 pathway.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

